Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Therapeutic Index01:13

Therapeutic Index

The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each indication due to...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Establishing a health information exchange research network (HIERN) to support population health studies.

NPJ digital medicine·2026
Same author

Evaluating NLP Approaches to Extract Drug Indications.

AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science·2026
Same author

From Food to Clinic: Mapping FoodOn to the UMLS to Enable Nutritional Decision Support.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026
Same author

Building a collaborative ecosystem across the IDeA-CTR networks in response to a public health emergency.

Journal of clinical and translational science·2025
Same author

Barriers and facilitators to COVID-19 testing and vaccination: a qualitative focus group study among Rhode Island's Latine/Hispanic community.

Frontiers in health services·2025
Same author

"<i>They fell through the cracks:</i>" caregiver perspectives on the difficulties of COVID-19 implementation transitions for children and youth with special healthcare needs (CYSHCN).

Frontiers in pediatrics·2025

Related Experiment Video

Updated: May 24, 2026

TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients
09:00

TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients

Published on: April 13, 2021

THERA-IE: An AI-Enabled System for Therapeutic Indication Identification and Extraction from Biomedical Literature.

Indra Neil Sarkar1

  • 1Center for Biomedical Informatics, Brown University, Providence, Rhode Island, USA.

Studies in Health Technology and Informatics
|May 23, 2026
PubMed
Summary

This study introduces THERA-IE, an open-source framework using AI to extract drug-indication knowledge, including potential off-label uses, from biomedical literature. The system shows promise for scalable and reproducible therapeutic knowledge discovery.

Keywords:
LLMdrug indicationsnatural language processingoff-label use

More Related Videos

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

Related Experiment Videos

Last Updated: May 24, 2026

TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients
09:00

TBase - an Integrated Electronic Health Record and Research Database for Kidney Transplant Recipients

Published on: April 13, 2021

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
05:47

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems

Published on: June 13, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

Area of Science:

  • Computational Biology
  • Bioinformatics
  • Natural Language Processing

Background:

  • Maintaining comprehensive drug-indication knowledge is crucial for evidence-based prescribing but is challenging due to incomplete data, especially for off-label uses.
  • Biomedical literature and artificial intelligence (AI) models hold potential for capturing this underrepresented therapeutic information.

Purpose of the Study:

  • To present THERA-IE (Therapeutic Hypothesis Extraction and Relationship Analytics - Indication Extraction), an open-source framework for identifying putative therapeutic indications.
  • To evaluate the performance of large language models (LLMs) and other AI approaches in extracting drug-indication relationships from text.

Main Methods:

  • Utilized SemMedDB, PubMedBERT, and three open-source LLMs (Llama 3.2, MedLlama 3, Qwen 3) to analyze twenty FDA-approved drugs.
  • Implemented LLMs in both model-only ('Naïve') and literature-supported ('Literature-Based') modes.
  • Benchmarked system performance against DrugBank, measuring metrics like F1-score, precision, and recall.

Main Results:

  • Naïve Llama 3.2 achieved the highest overall F1-score (0.60 ± 0.18).
  • Literature-Based Llama 3.2 demonstrated the highest precision (0.67 ± 0.29).
  • SemMedDB yielded the highest recall (0.77 ± 0.25) but also the most false positives. THERA-IE identified an average of 4.8 plausible off-label indications per drug.

Conclusions:

  • The THERA-IE framework effectively extracts therapeutic knowledge, including potential off-label indications, from biomedical literature.
  • AI, particularly LLMs, offers a scalable and reproducible approach to supplement existing drug-indication databases.
  • This work highlights the potential for automated knowledge extraction to advance evidence-based medicine.